When Cancer Runs in the FamilyFebruary 09, 2004Almost all tumor types have a genetically based form Most cancers occur sporadically. At least 5.5 percent of cancer cases are based on a genetic predisposition. These are usually identified because first-degree relatives develop the same type of tumor. So far, scientists have presumed that only a few types of tumor have such a familial form. However, Professor Kari Hemminki of the Division of Molecular-Genetic Epidemiology of the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), has now found familial forms of almost all tumor types. In the families affected, both the offspring and siblings of a cancer sufferer are at an increased risk to develop the same disorder. Sweden with its extensive population statistics offers unique opportunities to study the genetic risks of cancer. The Swedish "family register", a record of all individuals born in Sweden after 1932 and their parents, contains more than 10 million individuals. Moreover, the Swedish Cancer Register records almost 100 percent of cancer cases occurring in the population. Integrating both databases, which are also used at DKFZ, Hemminki and his co-workers were able to analyze over three million families. He identified almost 5000 families in which several cases of the same type of tumor occurred - an indicator of familial cancer. Based on these data, epidemiologist Hemminki was able to calculate the familial risks for each tumor type with unprecedented accuracy. Hemminki found familial forms in 24 out of 25 tumor types. Familial tumors were most frequent in prostrate cancer at about 15% of cases, followed by intestinal cancer (10%) and breast cancer (8.5%). Familial cancers were least frequent in connective tissue tumors (0.4%) and testicular tumors (0.5%). The degree of familial clustering of cancer also varies considerably among the different types of cancer. The highest genetic risk was found in families with testicular cancer. The sons of affected fathers had a fourfold increased risk compared to sons of families without testicular cancer, the brothers of affected individuals even had a ninefold increased risk to develop this cancer. As opposed to testicular cancer, familial forms of Hodgkin's disease, a type of lymphoma, had been unknown to date. Hemminki identified familial cases of this type of tumor, which also exhibited a strong familial risk: In children of affected persons the risk was increased almost fivefold, in siblings even sixfold. A strong genetic component was also revealed in families with non-medullary thyroid cancer, esophageal cancer and a certain type of bone cancer (multiple myeloma). The more common cancer types such as cancers of the prostate, kidney, skin, stomach and lung, leukemias and endocrinal tumors also occur in a familial form, even more frequently than previously thought. Hemminki observed particulary high risks to develop the disease in families with more than two cases in first-degree relatives and/or early age of onset. Both indicators suggest a strong genetic predisposition to the respective cancer and should possibly give cause for genetic counseling. In general, Hemminki's findings show that current genetic counseling practice covers only a fraction of familial cancers. Hemminki rejects the argument that the observed familial clustering of cancer cases could also be caused by shared environmental factors. In previous studies with married couples he had shown that a parallel increase in cancer risks only occurred in tumors that are strictly environmentally caused (e.g., lung or genital cancers). However, the risk usually remains far below that of genetically caused tumors. Deutsches Krebsforschungszentrum |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." AIDS research reveals a lack of family-planning programs in Uganda University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception. Possible Link Studied Between Childhood Abuse and Early Cellular Aging Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University. Rare pancreatic cancer patients may live longer when treated with radiation therapy Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Saving the single cysteine: new antioxidant system found We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||